Isoliquiritigenin, a potential therapeutic agent for treatment of inflammation-associated diseases
Bibliographic Data
| ID | 14737666 |
|---|---|
| Authors | Ziyi Chen (0000-0001-6790-1258, Beijing University of Chinese Medicine), Wenwen Ding (0009-0001-4805-6906, Beijing University of Chinese Medicine), Xiaoxue Yang (Beijing University of Chinese Medicine), Tiangong Lu (Beijing University of Chinese Medicine, corresponding author), Ying Liu (0000-0001-5584-7805, Beijing University of Chinese Medicine, corresponding author) |
| Year | 2024 |
| Volume | 318 |
| Issue | Pt B |
| Pages | 117059 |
| Publication date | 2024-01-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2023.117059 |
| PMID | 37604329 |
| OpenAlex | W4386012808 |
| Language | EN |
| Citations received | 3 |
| References cited | 175 |
Glycyrrhiza uralensis · Inflammation · Isoliquiritigenin · MAPK/ERK pathway · Signal transduction · Traditional Chinese medicine · Traditional medicine · Chemistry · Ginseng Biological Effects and Applications · Hormonal Regulation and Hypertension · Medicine · Pharmacological Effects of Natural Compounds · Biochemistry · Immunology · Pharmacology
Bioactive components and mechanisms of the traditional Chinese herbal formula Xuefu Zhuyu formula in the treatment of cardiovascular and cerebrovascular diseases
Yishen Qianggu Mixture formulation suppresses osteometabolic inflammation by modulating the IL-17/NF-κB/Mapk signaling axis
Study on the therapeutic mechanism of HJ granules in a rat model of urinary tract infection caused by Escherichia coli
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage
Inflammation and cancer
A protective mechanism of licorice (Glycyrrhiza uralensis)
Plants as a source of anti-cancer agents
The licorice flavonoid isoliquiritigenin attenuates Mycobacterium tuberculosis-induced inflammation through Notch1/NF-κB and Mapk signaling pathways
| Unique citing works | 3 |
|---|---|
| Citations per year | 1,5 |
| Citation span | 2024 - 2026 (3) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 2 |